Skip to content

The effect of inducer drugs knowing ovulation fertility after IUI procedure

Comparison of Clomiphene Citrate and Letrozole in pregnancy rate after intrauterine insemination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201106256871N2
Enrollment
65
Registered
2012-08-08
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility associated with male factors. Female infertility associated with male factors

Interventions

Intervention 1: Letrozole group(group A) is administrated tablet Letrozole 10miligram,daily,orally,from 3th-7th day of menstural cycle and two gonadotropin in 8th day and one gonadotropin in 9th day o
Treatment - Drugs
Letrozole group(group A) is administrated tablet Letrozole 10miligram,daily,orally,from 3th-7th day of menstural cycle and two gonadotropin in 8th day and one gonadotropin in 9th day of menstural cycl
Clomiphene Citrate group(group B) is administrated tab CC 100 mg,daily,orally,from 3th-7th day of menstural cycle and two gonadotropins in 8th day and one gonadotropin in 9th day of menstural cycle.Am

Sponsors

Management Research of Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: duration of infertility for more than a year, less than 35 years of age, ensuring the openness of the fallopian tubes at laparoscopy or hysterosonography and attended at least 10 million sperm per milliliter of semen. Exclusion criteria: age greater than 35 years, moderate and severe endometriosis, basal serum FSH> 10mIU/ml, Hyprprvlaktynvma, hyperthyroidism, Cushing's syndrome, heart and liver disorders, and nonclassic Congenital adrenal hyperplasia, drugs and other drugs Zddyabt hormonal, organic pelvic diseases, previous pelvic Vjrahy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The number of follicles larger than 14milimeter. Timepoint: day of human chrionic gonadotropin administration. Method of measurement: Trans Vaginal Sonography.;Endometrial thickness. Timepoint: Day of administration hCG. Method of measurement: Trans Vaginal Sonography.

Secondary

MeasureTime frame
Multiple pregnancy. Timepoint: 14 days after confirmation of chemical pregnancy. Method of measurement: Trans Vaginal Sonography.;Ovarian Hyper Stimulation Syndrom. Timepoint: after confirmation pregnancy. Method of measurement: History and Phisical exam and symptoms.;Chemical pregnancy. Timepoint: 16 day after administration of human chorionic gonadotropin. Method of measurement: ß-hCG.;Clinical Pregnancy. Timepoint: 14 day after confirmation of chemical pregnancy. Method of measurement: Trans Vaginal Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahnaz Ahmadi

Bushehr University of Medical Science

ahmadi@bpums.ac.irzhasani91@yahoo.com+98 77 1555 8860

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026